Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.

Saved in:
Bibliographic Details
Title: Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.
Authors: Gao, Xinyu1,2 (AUTHOR), Liu, Zhenjiang3 (AUTHOR), Xu, Zhaoting1,2 (AUTHOR), Liu, Ke3 (AUTHOR), Zhang, Yiming4 (AUTHOR), Yu, Jing3 (AUTHOR), Wang, Xu3 (AUTHOR), Cheng, Xinghua5 (AUTHOR), Ni, Chao4 (AUTHOR), Wang, Pin3,6 (AUTHOR), Liu, Yarong3 (AUTHOR), Hong, Xinfang7 (AUTHOR) xfhong123@126.com, Sun, Jingwei3 (AUTHOR) jingwei.sun@grit-bio.com, Zhao, Bing2,4 (AUTHOR) bingzhao@ncu.edu.cn
Source: Cellular Oncology (2211-3428). Apr2026, Vol. 49 Issue 2, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-026-01172-y